fibin Knockout Cell Line (C2C12)

Neither model is inherently better — the right choice depends on the experimental question. The Knockout line is appropriate when asking whether Fibin is required for a process such as myogenic differentiation, regeneration response, or developmental program execution. Overexpression is appropriate when asking whether forced Fibin expression is sufficient to drive or enhance these processes — useful given Fibin's relatively low baseline expression in undifferentiated C2C12. For researchers entering Fibin biology, the EDITGENE Knockout line is the more conservative starting point: loss-of-function phenotypes are easier to interpret for emerging factors where reference data is still being established. The strongest experimental design combines both — a Knockout phenotype rescued by Fibin re-introduction substantially strengthens the conclusion that the phenotype is Fibin-specific rather than off-target editing.

Primary applications: • Differentiation phenotyping: time-course assays (24–96h post-induction) with fusion index quantification and myotube morphology scoring to assess Fibin's contribution to C2C12 differentiation capacity. • Myogenic marker profiling: Western blot or immunofluorescence for MyoD, Myogenin, MRF4, and MyHC across differentiation stages to localize which phase of the program is affected. • Transcriptomic analysis: RNA-seq at matched differentiation stages to identify transcriptional changes associated with Fibin loss; results are hypothesis-generating and require targeted follow-up validation. • Regeneration pathway studies: Notch, Wnt, and IGF pathway activity assays in the knockout background. EDITGENE recommends confirming protein-level knockout by Western blot before proceeding to downstream assays.

Yes. Key considerations for rescue experiments in this model: • Construct design: use a codon-modified or 3' UTR-truncated Fibin sequence to avoid re-targeting by the original guide RNA. An N- or C-terminal tag (FLAG, HA) allows unambiguous detection of exogenous protein. • Delivery method: stable lentiviral or PiggyBac integration is preferable for differentiation assays that run over multiple days; transient transfection introduces expression variability that complicates fusion index quantification. • Differentiation timing: the choice of whether to express Fibin in proliferating myoblasts versus during differentiation matters — Fibin may have stage-specific functions. Inducible (Tet-On) systems allow temporal control and are recommended where the relevant stage is unclear. • Functional validation: rescue should restore the knockout phenotype (fusion index, marker expression). For an emerging factor like Fibin, including a control rescue with an unrelated protein helps rule out non-specific effects of viral integration on differentiation. C2C12 cells tolerate lentiviral transduction and antibiotic selection without significant loss of differentiation capacity, making this line well-suited for generating stable rescue sublines.